SABR versus conventional fractionation regimens in NSCLC - Authors' reply
Lancet Oncol
.
2019 May;20(5):e232.
doi: 10.1016/S1470-2045(19)30232-3.
Authors
David Ball
1
,
Alan Herschtal
2
Affiliations
1
Peter MacCallum Cancer Centre, Melbourne 3000, VIC, Australia. Electronic address: david.ball@petermac.org.
2
Peter MacCallum Cancer Centre, Melbourne 3000, VIC, Australia.
PMID:
31044709
DOI:
10.1016/S1470-2045(19)30232-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Non-Small-Cell Lung / surgery*
Dose Fractionation, Radiation
Humans
Lung Neoplasms / surgery*
Radiosurgery*